Pricing Log in Create free account

Dyne Therapeutics, Inc. (DYN) vs Enliven Therapeutics, Inc. (ELVN)

Dyne Therapeutics, Inc. and Enliven Therapeutics, Inc. are both Biotechnology companies. Dyne Therapeutics, Inc. and Enliven Therapeutics, Inc. are of similar size ($3.3B and $3.2B). Across the 10 metrics below, Enliven Therapeutics, Inc. leads on 9 and Dyne Therapeutics, Inc. on 1.

Valuation

Metric DYN ELVN Biotechnology median
P/E n/m n/m 10.26
P/S n/m n/m 9.18
P/B 4.13 3.34 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales n/m n/m 8.98
Earnings yield (19.00%) (3.69%) (34.89%)
Free cash flow yield (16.56%) (2.24%) (24.52%)

Profitability

Metric DYN ELVN Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (81.57%) (15.31%) (50.12%)
Return on assets (60.29%) (14.98%) (45.60%)
Return on invested capital (1,956.27%) 0.00% 0.00%

Growth

Metric DYN ELVN Biotechnology median
Revenue growth (TTM) — — 6.26%
EPS growth (last fiscal year) (2.97%) 3.17% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DYN ELVN Biotechnology median
Debt to equity 0.30 0.00 0.00
Current ratio 12.02 64.07 4.89
Net debt to EBITDA 2.05 3.87 1.01

Dividend

Metric DYN ELVN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric DYN ELVN Biotechnology median
Market cap 3.24b 3.28b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack